Cargando…

Ocular surface squamous neoplasia in HIV-infected patients: current perspectives

Ocular surface squamous neoplasia (OSSN) refers to a spectrum of conjunctival and corneal epithelial tumors including dysplasia, carcinoma in situ, and invasive carcinoma. In this article, we discuss the current perspectives of OSSN associated with HIV infection, focusing mainly on the epidemiology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathi, Shweta Gupta, Ganguly Kapoor, Anasua, Kaliki, Swathi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857154/
https://www.ncbi.nlm.nih.gov/pubmed/29559813
http://dx.doi.org/10.2147/HIV.S120517
_version_ 1783307424770293760
author Rathi, Shweta Gupta
Ganguly Kapoor, Anasua
Kaliki, Swathi
author_facet Rathi, Shweta Gupta
Ganguly Kapoor, Anasua
Kaliki, Swathi
author_sort Rathi, Shweta Gupta
collection PubMed
description Ocular surface squamous neoplasia (OSSN) refers to a spectrum of conjunctival and corneal epithelial tumors including dysplasia, carcinoma in situ, and invasive carcinoma. In this article, we discuss the current perspectives of OSSN associated with HIV infection, focusing mainly on the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of these tumors in patients with HIV. Upsurge in the incidence of OSSN with the HIV pandemic most severely affected sub-Saharan Africa, due to associated risk factors, such as human papilloma virus and solar ultraviolet exposure. OSSN has been reported as the first presenting sign of HIV/AIDS in 26%–86% cases, and seropositivity is noted in 38%–92% OSSN patients. Mean age at presentation of OSSN has dropped to the third to fourth decade in HIV-positive patients in developing countries. HIV-infected patients reveal large aggressive tumors, higher-grade malignancy, higher incidence of corneal, scleral, and orbital invasion, advanced-stage T4 tumors, higher need for extended enucleation/exenteration, and increased risk of tumor recurrence. Current management of OSSN in HIV-positive individuals is based on standard treatment guidelines described for OSSN in the general population, as there is little information available about various treatment modalities or their outcomes in patients with HIV. OSSN can occur at any time in the disease course of HIV/AIDS, and no significant trend has been discovered between CD4 count and grade of OSSN. Furthermore, the effect of highly active antiretroviral therapy on OSSN is controversial. The current recommendation is to conduct HIV screening in all cases presenting with OSSN to rule out undiagnosed HIV infection. Patient counseling is crucial, with emphasis on regular follow-up to address high recurrence rates and early presentation to an ophthalmologist for of any symptoms in the unaffected eye. Effective evidence-based interventions are needed to allow early diagnosis and treatment, as well as prevention of the disease.
format Online
Article
Text
id pubmed-5857154
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58571542018-03-20 Ocular surface squamous neoplasia in HIV-infected patients: current perspectives Rathi, Shweta Gupta Ganguly Kapoor, Anasua Kaliki, Swathi HIV AIDS (Auckl) Review Ocular surface squamous neoplasia (OSSN) refers to a spectrum of conjunctival and corneal epithelial tumors including dysplasia, carcinoma in situ, and invasive carcinoma. In this article, we discuss the current perspectives of OSSN associated with HIV infection, focusing mainly on the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of these tumors in patients with HIV. Upsurge in the incidence of OSSN with the HIV pandemic most severely affected sub-Saharan Africa, due to associated risk factors, such as human papilloma virus and solar ultraviolet exposure. OSSN has been reported as the first presenting sign of HIV/AIDS in 26%–86% cases, and seropositivity is noted in 38%–92% OSSN patients. Mean age at presentation of OSSN has dropped to the third to fourth decade in HIV-positive patients in developing countries. HIV-infected patients reveal large aggressive tumors, higher-grade malignancy, higher incidence of corneal, scleral, and orbital invasion, advanced-stage T4 tumors, higher need for extended enucleation/exenteration, and increased risk of tumor recurrence. Current management of OSSN in HIV-positive individuals is based on standard treatment guidelines described for OSSN in the general population, as there is little information available about various treatment modalities or their outcomes in patients with HIV. OSSN can occur at any time in the disease course of HIV/AIDS, and no significant trend has been discovered between CD4 count and grade of OSSN. Furthermore, the effect of highly active antiretroviral therapy on OSSN is controversial. The current recommendation is to conduct HIV screening in all cases presenting with OSSN to rule out undiagnosed HIV infection. Patient counseling is crucial, with emphasis on regular follow-up to address high recurrence rates and early presentation to an ophthalmologist for of any symptoms in the unaffected eye. Effective evidence-based interventions are needed to allow early diagnosis and treatment, as well as prevention of the disease. Dove Medical Press 2018-03-14 /pmc/articles/PMC5857154/ /pubmed/29559813 http://dx.doi.org/10.2147/HIV.S120517 Text en © 2018 Rathi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Rathi, Shweta Gupta
Ganguly Kapoor, Anasua
Kaliki, Swathi
Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
title Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
title_full Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
title_fullStr Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
title_full_unstemmed Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
title_short Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
title_sort ocular surface squamous neoplasia in hiv-infected patients: current perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857154/
https://www.ncbi.nlm.nih.gov/pubmed/29559813
http://dx.doi.org/10.2147/HIV.S120517
work_keys_str_mv AT rathishwetagupta ocularsurfacesquamousneoplasiainhivinfectedpatientscurrentperspectives
AT gangulykapooranasua ocularsurfacesquamousneoplasiainhivinfectedpatientscurrentperspectives
AT kalikiswathi ocularsurfacesquamousneoplasiainhivinfectedpatientscurrentperspectives